Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets - GBI Research Reports

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets - GBI Research Reports
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
Published Sep 01, 2011
114 pages — Published Sep 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research has released its latest research Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets, which provides insights into drivers, barriers and trends in the outsourcing of drug development tin the global pharmaceutical and biotechnology industry. The report profiles top 20 contract research organization in Asia-Pacific and provides business overview, business snapshot and the list of alliances made in the period 2005 to 2010

In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by GBI Researchs team of experts.

Scope

The scope of this report includes -
- Analysis of drivers and barriers in the outsourcing of drug development processes
- Analysis of different functional models in the global CRO industry
- Analysis of key reasons for the pharmaceutical industry to outsource drug development

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Identify the top 20 contract research organizations in Asia-pacific
- Identify major international pharmaceutical companies who have made alliances with the Asia-Pacific CROs
- Understand the service offerings of major CROs in the Asia-Pacific

  
Source:
Document ID
GBIHC106MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents47
  List of Tables81
  List of Figures92
Contract Research Outsourcing Introduction111
  GBI Research Report Guidance111
Top 20 Contract Research Organizations Overview128
  Global Contract Research Outsourcing121
  The Clinical Research Process131
    Drug Discovery Phase131
    Pre-Clinical Phase141
    Phase I141
    Phase II141
    Phase III141
    Review and Approval from the Regulatory Agencies141
    Post-Marketing Studies141
  Outsourcing of Clinical Research and Trial Processes151
    Clinical Research Outsourcing Perceived to be a Solution to Problems Such as Rising Costs or Low Productivity151
    Strategic Outsourcing Improves Value for Outsourcing Companies151
  Key Reasons for Outsourcing to Contract Research Organizations161
    Gaining Cost Reductions is a Key Reason for Contract Research Outsourcing171
    CROs Engaged in Reducing Time to Market in Order to Achieve a Competitive Edge171
    Data Management Allows Biopharmaceutical Companies to Focus on Core Competencies181
    Evolving Risk Sharing Agreements Encourage Biopharmaceutical Companies to Increase Contract Research Outsourcing181
    CROs Help to Improve Clinical Research Quality181
    Small and Medium Biopharmaceutical Companies can Capitalize on the Resources of CROs191
    Biopharmaceutical Companies Benefit from New Technologies191
Contract Research Outsourcing Geographical Landscape2012
  Emerging Regions in the Global Contract Research Outsourcing Market211
    Latin America211
      Potential Advantages of the Latin American Contract Research Outsourcing Market211
    Central and Eastern Europe (CEE)211
      Potential Advantages of Central and East European Contract Research Outsourcing Market221
    India221
      Potential Advantages of the Indian Contract Research Outsourcing Market221
    China231
      Potential Advantages of the Chinese Contract Research Outsourcing Market231
  Why India and China?241
    Availability of Skilled Manpower242
    Scale of Available Resources for Clinical Development261
    Improved IP Protection in India and China261
    Government Support for the Drug Discovery Development271
      China271
      India271
    Risk Sharing Agreements: A Step Forward by Indian and Chinese Companies281
      Hutchison MediPharma with Merck KGaA and Eli Lilly &Co291
      Advinus Therapeutics with Ortho-McNeil-Janssen Pharmaceutical Inc, Genzyme Corporation and Merck &Co291
      Ranbaxy with Merck &Co and GlaxoSmithKline291
  SWOT Analysis292
  Conclusion311
Top 20 Contract Research Organizations Service Models323
  Contract Research Outsourcing Service Model321
    Fully Integrated Service Model321
    Functional Service Model331
  Criteria for Selecting a Contract Research Organization341
Top 20 Contract Research Organizations Market Characterization356
  The Contract Research Outsourcing Market will be Driven by Demand from Biopharmaceutical Industry351
  Key Market Drivers361
    Increasing R&D Expenditure and Decreasing Productivity in the Biopharmaceutical Industry361
    Stringent Regulations and Complex Clinical Trials361
    Restriction on Pricing and Reimbursement of Drugs371
    Increasing Number of Clinical Trials371
  Key Market Restraints/Challenges381
    Quality Concerns381
    Economic Recession381
  Contract Research Outsourcing Market Trends391
    Increase in the Number of Services Focusing on Late Stage Clinical Development391
    Globalization of Clinical Research and Trials391
    Strategic Partnerships with CROs401
    Advanced Technology to Enhance Drug Discovery Process401
Top 20 Contract Research Organizations Competitive Landscape4170
  Overview411
  Market Share Analysis and Competitive Profiling421
  Quintiles Transnational Corp.431
    Business Description431
    Snapshot441
    Strategic Consolidations453
    Financial Information481
    SWOT Analysis491
  Covance501
    Business Description501
    Snapshot501
    Strategic Consolidations511
    Financial Information521
    SWOT Analysis531
  Pharmaceutical Product Development541
    Business Description541
    Snapshot541
    Strategic Consolidations554
    Financial Information591
    SWOT Analysis601
  Charles River Laboratories611
    Business Description611
    Snapshot611
    Strategic Consolidations622
    Financial Information641
    SWOT Analysis651
  PAREXEL661
    Business Description661
    Snapshot661
    Strategic Consolidations672
    Financial Information691
    SWOT Analysis701
  ICON711
    Business Overview711
    Snapshot711
    Strategic Consolidations721
    Financial Information731
  INC Research741
    Business Description741
    Snapshot741
    Strategic Consolidations751
    Financial Information761
  PharmaNet Development Group Inc.771
    Business Description771
    Snapshot771
    Strategic Consolidations781
    Financial Information791
  PRA International801
    Business Overview801
    Snapshot801
    Strategic Consolidations811
  CMIC821
    Business Description821
    Snapshot821
    Strategic Consolidations831
    Financial Information841
  WuXi AppTec851
    Business Description851
    Snapshot851
    Strategic Consolidations861
    Financial Information871
  Galapagos NV871
    Business Description871
    BioFocus881
    Snapshot881
    Strategic Consolidations895
    Financial Information941
  LAB Research Inc951
    Business Description951
    Snapshot951
    Strategic Consolidations961
    Financial Information961
  ReSearch Pharmaceutical Services971
    Business Description971
    Snapshot971
    Strategic Consolidations981
    Financial Information991
  Omnicare Clinical Research, Inc991
    Business Overview991
    Snapshot1001
    Strategic Consolidations1001
  SGS1011
    Business Description1011
    Snapshot1011
  United BioSource Corporation1021
    Business Description1021
    Snapshot1021
    Strategic Consolidations1031
  BioClinica1041
    Business Description1041
    Snapshot1041
    Strategic Consolidations1041
    Financial Information1051
  Aptuit1061
    Business Overview1061
    Snapshot1061
    Strategic Consolidations1071
  Chiltern1081
    Business Overview1081
    Snapshot1081
    Strategic Consolidations1091
    Financial Information1101
Top 20 Contract Research Organizations - Appendix1114
  Market Definitions1111
  Abbreviations1111
  Research Methodology1122
    Coverage1121
    Secondary Research1131
    Primary Research1131
    Expert Panel Validation1131
  Contact Us1141
  Disclaimer1141
  Sources1141

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets" Sep 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Top-20-Contract-Research-Organizations-CRO-Asia-Pacific-Especially-India-and-China-Positioned-to-Benefit-from-Rising-Financial-and-Regulatory-Pressures-in-Western-Pharmaceutical-Markets-2115-244>
  
APA:
GBI Research Reports. (2011). Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets Sep 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Top-20-Contract-Research-Organizations-CRO-Asia-Pacific-Especially-India-and-China-Positioned-to-Benefit-from-Rising-Financial-and-Regulatory-Pressures-in-Western-Pharmaceutical-Markets-2115-244>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.